← Leaderboards
Chad Michael Walesky
Brigham And Women'S Hospital
$179,045
Attributed
$179,045
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $63K · FY2016–18$100K$75K$50K$25K$0
'16
'17
'18
Funding mix
By agency
NIH$179,045 · 1
By mechanism
F32$179,045 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Wolfram Goessling$18,674,633
- Chinweike Ukomadu$2,314,952
- David Branch Moody$37,151,091
- Edward Giovannucci$20,500,695
- Paul J. Wrighton$173,960
Others in their field
Top investigators on “Endoderm”
- Kenneth S Zaret · Institute For Cancer Research$18,996,273
- Bing Ren · Ludwig Institute For Cancer Research$16,259,891
- Anna-Katerina Hadjantonakis · Sloan-Kettering Inst Can Research$15,190,945
- Edward E Morrisey · University Of Pennsylvania$13,836,395
- Darrell N. Kotton · Boston University Medical Campus$10,299,643
- George Stamatoyannopoulos · University Of Washington$9,365,795
Research focus
EndodermAffectAgonistAdultBeta CateninBile DuctBile Duct CarcinomaBiliaryAnimal ModelAdvanced DiseaseCancer TherapyCell Differentiation ProcessCell GrowthCell ProliferationCellsChemical GeneticsCholangiocarcinomaCholangiocyteDiagnosisBiliary TractDominant-Negative MutationBiologyEmbryoEquilibrium
Grant awards (4)
A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation$63,034
F32 · FY2018 · DK · contact PI
A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation$59,166
F32 · FY2017 · DK · contact PI
A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation$727
F32 · FY2017 · DK · contact PI
A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation$56,118
F32 · FY2016 · DK · contact PI